After treatment with CAR-T cells — immune cells engineered to attack cancer — patients sometimes tell their doctors they feel like they have “brain fog,” or forgetfulness and difficulty concentrating.
A new Stanford Medicine-led study shows that CAR-T cell therapy causes mild cognitive impairments, independent of other cancer treatments, and that this happens via the same cellular mechanism as cognitive impairment from two other causes: chemotherapy and respiratory infections such as flu…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply